ID
44776
Descripción
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
Link
https://clinicaltrials.gov/show/NCT01255046
Palabras clave
Versiones (3)
- 30/8/15 30/8/15 -
- 13/4/21 13/4/21 - Dr. rer. medic Philipp Neuhaus
- 18/11/21 18/11/21 -
Titular de derechos de autor
Sinphar Pharmaceutical Co., Ltd
Subido en
18 de noviembre de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Descripción
Exclusion Criteria
Descripción
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0024485
- UMLS CUI [2]
- C0040405
- UMLS CUI [3]
- C0587081
Descripción
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0007682
Descripción
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0004936
Descripción
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
- UMLS CUI [2,1]
- C0018674
- UMLS CUI [2,2]
- C0234387
Descripción
patient with a history of hypersensitivity to study drugs;
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0013182
Descripción
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3843040
Descripción
participation in any research study within the last 30 days;
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0008976
Descripción
patient with significant alcohol or drug abuse as judged by the investigator.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0237123
Similar models
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [2])
C0587081 (UMLS CUI [3])
C0234387 (UMLS CUI [1,2])
C0018674 (UMLS CUI [2,1])
C0234387 (UMLS CUI [2,2])